Results 41 to 50 of about 3,407,318 (341)

Systemic antiplatelet agents and anticoagulants in eyes with branch retinal vein occlusion

open access: yesTherapeutic Advances in Ophthalmology, 2021
Purpose: The purpose of this study was to investigate the effect of systemic antiplatelet agents and anticoagulants on the structural and functional outcomes of eyes with branch retinal vein occlusion (BRVO).
Pali P. Singh   +7 more
doaj   +1 more source

Systematic review and meta-analysis of optimal P2Y₁₂ blockade in dual antiplatelet therapy for patients with diabetes with acute coronary syndrome [PDF]

open access: yes, 2016
Background: Patients with diabetes are at increased risk of acute coronary syndromes (ACS) and their mortality and morbidity outcomes are significantly worse following ACS events, independent of other comorbidities.
Brown, Oliver I   +2 more
core   +1 more source

More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions. [PDF]

open access: yes, 2018
© 2018 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.Common to the pathogenesis of acute coronary syndromes (ACS) is the formation of arterial thrombus, which results from platelet activation and triggering of the ...
Farag M   +6 more
core   +3 more sources

Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review [PDF]

open access: yes, 2016
Objective:Atrial Fibrillation (AF) is associated with dementia. If AF-related cognitive decline is driven by cerebral embolic events, thromboprophylaxis may impact on this.
Lane, Deirdre A.   +4 more
core   +2 more sources

Novel agents for anti-platelet therapy

open access: yesJournal of Hematology & Oncology, 2011
Anti-platelet therapy plays an important role in the treatment of patients with thrombotic diseases. The most commonly used anti-platelet drugs, namely, aspirin, ticlopidine, and clopidogrel, are effective in the prevention and treatment of cardio ...
Ji Xuebin, Hou Ming
doaj   +1 more source

Current Antiplatelet Treatment Strategy in Patients with Diabetes Mellitus [PDF]

open access: yesDiabetes & Metabolism Journal, 2015
Patients with diabetes mellitus (DM) have accelerated atherosclerosis with an increased risk for atherothrombotic cardiovascular complications. A state of high platelet reactivity and activation, hypercoagulability (prothrombotic state) and a subdued ...
Jung Hwa Jung   +3 more
doaj   +1 more source

Efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion

open access: yesКардиоваскулярная терапия и профилактика, 2022
Aim. To evaluate the efficacy and safety of various antithrombotic regimens after left atrial appendage occlusion (LAAO) in real clinical practice.Material and methods.
D. V. Pevsner   +3 more
doaj   +1 more source

Adherence to secondary stroke prevention strategies - Results from the German stroke data bank [PDF]

open access: yes, 2003
Only very limited data are available concerning patient adherence to antithrombotic medication intended to prevent a recurrent stroke. Reduced adherence and compliance could significantly influence the effects of any stroke prevention strategies.
Busse, O.   +4 more
core   +1 more source

Platelet-Derived Extracellular Vesicles as Target of Antiplatelet Agents. What Is the Evidence?

open access: yesFrontiers in Pharmacology, 2019
Platelet-derived large extracellular vesicles (often referred to as microparticles in the field of cardiovascular disease) have been identified as effector in the atherothrombotic process, therefore representing a target of pharmacological intervention ...
F. Taus   +3 more
semanticscholar   +1 more source

A hopeful therapy for Niemann-Pick C diseases [PDF]

open access: yes, 2017
Not abstract ...
Erickson, Robert P.   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy